Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories Intl (NY: CRL ) 188.68 +6.20 (+3.40%) Official Closing Price Updated: 4:10 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Charles River Laboratories Intl < Previous 1 2 3 4 5 6 7 8 9 Next > Charles River Launches New Retrogenix® Non-Human Protein Library October 17, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call October 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Provides Translational Expertise at Neuroscience 2024 October 03, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease October 02, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research September 17, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience September 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at Baird and Morgan Stanley Conferences September 03, 2024 From Charles River Laboratories International, Inc. Via Business Wire CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm August 13, 2024 From Bragar Eagel & Squire Via GlobeNewswire Charles River Laboratories Announces Second-Quarter 2024 Results August 07, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development July 30, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery July 24, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call July 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River to Perform Plasmid Manufacturing for AAVantgarde July 08, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus June 25, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy June 17, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives June 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville June 06, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research June 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at William Blair and Jefferies Conferences June 03, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development May 30, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Announces First-Quarter 2024 Results May 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP May 02, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally April 22, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing April 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call April 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology April 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics April 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River to Perform Plasmid Production for Ship of Theseus April 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 02, 2024 From Bragar Eagel & Squire Via GlobeNewswire Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 April 01, 2024 From Charles River Laboratories International, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
